Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...
A Lincoln doctor who suffered a spinal cord injury now leads a spinal cord injury unit, and tries to be open with his patients about his own injury while helping ...
Lineage Cell Therapeutics initiates DOSED clinical study of OPC1 for spinal cord injury: Carlsbad, California Thursday, February 13, 2025, 14:00 Hrs [IST] Lineage Cell Therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback